CD8A and leukemia: Taken together, the results of these experiments indicate that IL-15SA significantly increases the anti-lymphoma /leukemia activity in murine HSCT by effectively promoting the effector/memory CD8+ T and NK cell expansion and potently enhancing their effector functions.